Lai, X., Keller, C., Santos, G., Schaft, N., Dörrie, J. and Vera, J. (2022). "Multi-Level Computational Modeling of Anti-Cancer Dendritic Cell Vaccination Utilized to Select Molecular Targets for Therapy Optimization." Frontiers in Cell and Developmental Biology 9.

Lai, X., Zhou, J., Wessely, A., Heppt, M., Maier, A., Berking, C., Vera, J. and Zhang, L. (2022). "A disease network-based deep learning approach for characterizing melanoma." Int J Cancer 150(6): 1029–1044.

Pützer, B.M. and Sabapathy, K. (2022). "Editorial: Multidisciplinary Approaches in Exploring Cancer Heterogeneity, TME and Therapy Resistance: Perspectives for Systems Medicine." Frontiers in Cell and Developmental Biology 10.

Zierold, S., Akcetin, L.S., Gresser, E., Maier, A.M., König, A., Kramer, R., Theurich, S., Tomsitz, D., Erdmann, M., French, L.E., Rudelius, M. and Heinzerling, L. (2022). "Checkpoint-inhibitor induced Polyserositis with Edema." Cancer Immunology, Immunotherapy.


Bailey, C.G., Gupta, S., Metierre, C., Amarasekera, P.M.S., O'Young, P., Kyaw, W., Laletin, T., Francis, H., Semaan, C., Sharifi Tabar, M., Singh, K.P., Mullighan, C.G., Wolkenhauer, O., Schmitz, U. and Rasko, J.E.J. (2021). "Structure-function relationships explain CTCF zinc finger mutation phenotypes in cancer." Cell Mol Life Sci.

Faas, M., Ipseiz, N., Ackermann, J., Culemann, S., Grüneboom, A., Schröder, F., Rothe, T., Scholtysek, C., Eberhardt, M., Böttcher, M., Kirchner, P., Stoll, C., Ekici, A., Fuchs, M., Kunz, M., Weigmann, B., Wirtz, S., Lang, R., Hofmann, J., Vera, J., Voehringer, D., Michelucci, A., Mougiakakos, D., Uderhardt, S., Schett, G. and Krönke, G. (2021). "IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation." Immunity 54(11): 2531–2546.e2535.

Hornschuh, M., Wirthgen, E., Wolfien, M., Singh, K.P., Wolkenhauer, O. and Dabritz, J. (2021). "The role of epigenetic modifications for the pathogenesis of Crohn's disease." Clinical Epigenetics 13(1): 108.

Husain, B., Kirchberger, M.C., Erdmann, M., Schüpferling, S., Abolhassani, A.-R., Fröhlich, W., Berking, C. and Heinzerling, L. (2021). "Inflammatory markers in autoimmunity induced by checkpoint inhibitors." Journal of Cancer Research and Clinical Oncology 147(6): 1623-1630.

Lai, X., Dreyer, F.S., Cantone, M., Eberhardt, M., Gerer, K.F., Jaitly, T., Uebe, S., Lischer, C., Ekici, A., Wittmann, J., Jack, H.M., Schaft, N., Dorrie, J. and Vera, J. (2021). "Network- and systems-based re-engineering of dendritic cells with non-coding RNAs for cancer immunotherapy." Theranostics 11(3): 1412-1428.

Logotheti, S., Richter, C., Murr, N., Spitschak, A., Marquardt, S. and Putzer, B.M. (2021). "Mechanisms of Functional Pleiotropy of p73 in Cancer and Beyond." Front Cell Dev Biol 9: 737735.

Marquardt, S., Pavlopoulou, A., Takan, I., Dhar, P., Pützer, B.M. and Logotheti, S. (2021). "A Systems-Based Key Innovation-Driven Approach Infers Co-option of Jaw Developmental Programs During Cancer Progression." Front Cell Dev Biol 0.

Sauerer, T., Lischer, C., Weich, A., Berking, C., Vera, J. and Dorrie, J. (2021). "Single-Molecule RNA Sequencing Reveals IFNgamma-Induced Differential Expression of Immune Escape Genes in Merkel Cell Polyomavirus-Positive MCC Cell Lines." Frontiers in Microbiology 12: 785662.

Vera, J., Lischer, C., Nenov, M., Nikolov, S., Lai, X. and Eberhardt, M. (2021). "Mathematical Modelling in Biomedicine: A Primer for the Curious and the Skeptic." International Journal of Molecular Sciences 22(2): 547.

Wagner, N., Eberhardt, M., Vera, J., Cuomo, F., Blume, K., Galster, S., Achenbach, S., Laffert, B., Kahlert, H., Schuler, G., Berking, C. and Baur, A. (2021). "Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controls." World Allergy Organ J 14(9): 100583.


Logotheti, S., S. Marquardt, S. K. Gupta, C. Richter, B. A. H. Edelhäuser, D. Engelmann, J. Brenmoehl, C. Söhnchen, N. Murr, M. Alpers, K. P. Singh, O. Wolkenhauer, D. Heckl, A. Spitschak, and B. M. Pützer (2020). "LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1." Theranostics 10(21).

Logotheti, S., S. Marquardt, C. Richter, R. Sophie Hain, N. Murr, I. Takan, A. Pavlopoulou, and B. M. Pützer (2020). "Neural Networks Recapitulation by Cancer Cells Promotes Disease Progression: A Novel Role of p73 Isoforms in Cancer-Neuronal Crosstalk." Cancers (Basel) 12(12): 3789.

Serhan, C. N., S. K. Gupta, M. Perretti, C. Godson, E. Brennan, Y. Li, O. Soehnlein, T. Shimizu, O. Werz, V. Chiurchiù, A. Azzi, M. Dubourdeau, S. S. Gupta, P. Schopohl, M. Hoch, D. Gjorgevikj, F. M. Khan, D. Brauer, A. Tripathi, K. Cesnulevicius, D. Lescheid, M. Schultz, E. Särndahl, D. Repsilber, R. Kruse, A. Sala, J. Z. Haeggström, B. D. Levy, J. G. Filep, and O. Wolkenhauer (2020). "The Atlas of Inflammation Resolution (AIR)." Mol Aspects Med 74: 100894.

Singh, N., M. Eberhardt, O. Wolkenhauer, J. Vera, and S. K. Gupta (2020). "An integrative network-driven pipeline for systematic identification of lncRNA-associated regulatory network motifs in metastatic melanoma." BMC Bioinformatics 21(1): 1–17.


Diese Seite nutzt Website Tracking-Technologien von Dritten, um ihre Dienste anzubieten. Ich bin damit einverstanden und kann meine Einwilligung jederzeit mit Wirkung für die Zukunft widerrufen oder ändern.

Einstellungen Akzeptieren ImpressumDatenschutz